QRG Capital Management Inc. grew its position in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) by 6.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 39,865 shares of the medical equipment provider's stock after acquiring an additional 2,559 shares during the quarter. QRG Capital Management Inc. owned about 0.11% of Integer worth $4,902,000 as of its most recent filing with the SEC.
Other institutional investors have also bought and sold shares of the company. Opal Wealth Advisors LLC acquired a new stake in Integer in the first quarter worth about $28,000. Bessemer Group Inc. lifted its holdings in Integer by 73.1% in the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock worth $35,000 after purchasing an additional 125 shares during the period. SVB Wealth LLC acquired a new stake in Integer in the first quarter worth about $35,000. GAMMA Investing LLC lifted its holdings in Integer by 20.2% in the second quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider's stock worth $98,000 after purchasing an additional 134 shares during the period. Finally, Headlands Technologies LLC lifted its holdings in Integer by 1,234.8% in the first quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider's stock worth $145,000 after purchasing an additional 1,136 shares during the period. Institutional investors and hedge funds own 99.29% of the company's stock.
Analysts Set New Price Targets
ITGR has been the subject of several research analyst reports. Truist Financial reduced their price objective on shares of Integer from $145.00 to $137.00 and set a "buy" rating for the company in a report on Friday, July 25th. Raymond James Financial dropped their price target on shares of Integer from $150.00 to $143.00 and set an "outperform" rating on the stock in a research report on Friday, July 25th. Wells Fargo & Company dropped their price target on shares of Integer from $152.00 to $132.00 and set an "overweight" rating on the stock in a research report on Friday, July 25th. Wall Street Zen upgraded shares of Integer from a "hold" rating to a "buy" rating in a research report on Saturday, August 30th. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Integer in a research report on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $139.57.
Read Our Latest Report on Integer
Integer Price Performance
NYSE ITGR opened at $105.21 on Monday. The company has a market cap of $3.69 billion, a PE ratio of 46.35, a PEG ratio of 0.83 and a beta of 0.97. Integer Holdings Corporation has a 1 year low of $99.73 and a 1 year high of $146.36. The company has a current ratio of 3.41, a quick ratio of 2.18 and a debt-to-equity ratio of 0.72. The stock's 50-day moving average price is $105.65 and its two-hundred day moving average price is $114.03.
Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). The business had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. Integer had a net margin of 4.61% and a return on equity of 12.27%. Integer's revenue for the quarter was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. On average, analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current year.
Integer Profile
(
Free Report)
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Further Reading
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corporation (NYSE:ITGR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.